<DOC>
	<DOC>NCT00533910</DOC>
	<brief_summary>The purpose of this study is to determine whether alteration of gut flora with rifaximin can lead to improvement in driving performance, psychometric test performance, and quality of life in patients with minimal hepatic encephalopathy (MHE) and cirrhosis in a randomized, blinded, placebo-controlled trial.</brief_summary>
	<brief_title>Rifaximin in Minimal Hepatic Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Age 1865 years Cirrhosis diagnosed on clinical grounds MHE diagnosed by abnormalities in a psychometric battery (NCTA, NCTB, ICT BDT and DST impaired beyond 2 standard deviations of known control values on any of the above 3 tests will be considered to have MHE) Current drivers (valid driving license and driving at least 20 miles/week) All women of childbearing potential will be required to use effective contraception Current or recent (&lt; 6 month) use of alcohol (AUDIT questionnaire will be used; any cirrhotic with a value of &gt; 0 will be excluded) and a positive blood alcohol level Use of antibiotics within last 6 weeks Allergy to rifaximin, rifabutin, rifampin, or rifapentine Infection or gastrointestinal hemorrhage within the last 6 weeks Renal insufficiency Hepatocellular carcinoma Psychoactive drug use, including interferon concurrently Nondrivers and those who drive less than 20 miles/week Pregnancy and breastfeeding Excluding patients with OHE: Detailed neurological examination to check for dysarthria, asterixis, ataxia and disorientation Detailed historytaking from friends/relatives only after taking the patient's permission Minimental status examination &gt; 25 Episode of overt (clinical hepatic encephalopathy) within 6 months Current treatment with lactulose, rifaximin, zinc, or metronidazole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Minimal hepatic encephalopathy</keyword>
</DOC>